{"id":"W4410809617","doi":"10.1200/jco.2025.43.16_suppl.tps5119","title":"A phase 3 trial of the androgen receptor ligand-directed degrader, BMS-986365, versus investigator’s choice in patients with metastatic castration-resistant prostate cancer (CA071-1000 - rechARge).","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Medicine; Prostate cancer; Androgen receptor; Oncology; Internal medicine; Androgen; Cabazitaxel; Androgen deprivation therapy; Castration; Cancer; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002468458,0.00238863,0.002101778,0.0006232597,0.0005833869,0.001361109,0.001379853,0.002128875,0.008177105],"category_scores_gemma":[0.001516712,0.0007865657,0.002082001,0.0004830053,0.001367058,0.001584747,0.0004234241,0.00460376,0.001486353],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001254522,"about_ca_system_score_gemma":0.001853441,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001279253,"about_ca_topic_score_gemma":0.004520005,"domain_scores_codex":[0.9994043,0.0003028413,0.00002023832,0.00008870203,0.0000470538,0.0001368253],"domain_scores_gemma":[0.9988809,0.0002253173,0.0002487624,0.00009015515,0.00005420471,0.0005006965],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9031718,0.04599736,0.001527929,0.0004139122,0.0007312747,0.0001453901,0.0001881038,0.001406279,0.01159179,0.0003886345,0.00394434,0.03049323],"study_design_scores_gemma":[0.7803794,0.2140761,0.002140747,0.00001541238,0.0001794567,0.00009954395,0.00003565205,0.0008051216,0.0008620445,0.0003012178,0.00108212,0.00002330176],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9846,0.002006707,0.000756001,0.00125271,0.0004457767,0.005665505,0.001856382,0.0002324813,0.003184448],"genre_scores_gemma":[0.9812996,0.001417573,0.002258517,0.001982721,0.0003983898,0.00554709,0.002514545,0.00006116139,0.004520411],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008177105,"threshold_uncertainty_score":0.02735513,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1419942384453683,"score_gpt":0.4844084449019102,"score_spread":0.342414206456542,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}